Low expression of ZMYND8 correlates with aggressive features and poor prognosis in nasopharyngeal carcinoma

被引:7
作者
Chen, Jiewei [1 ,2 ]
Liu, Jun [1 ,2 ]
Chen, Xiaoting [1 ,2 ]
Li, Yong [1 ,2 ]
Li, Zizi [3 ]
Shen, Chengchao [1 ,2 ]
Chen, Keming [1 ,2 ]
Zhang, Xinke [1 ,2 ]
机构
[1] Sun Yat Sen Univ, Canc Ctr, Guangdong Key Lab Nasopharyngeal Carcinoma Diag &, Collaborat Innovat Ctr Canc Med,State Key Lab Onc, Guangzhou 510060, Guangdong, Peoples R China
[2] Sun Yat Sen Univ, Canc Ctr, Dept Pathol, 651 Dong Feng Rd East, Guangzhou 510060, Guangdong, Peoples R China
[3] Sun Yat Sen Univ, Affiliated Hosp 5, Dept Pathol, Zhuhai 519000, Peoples R China
来源
CANCER MANAGEMENT AND RESEARCH | 2019年 / 11卷
基金
中国国家自然科学基金;
关键词
ZMYND8; nasopharyngeal carcinoma; prognosis; PROTEIN; CANCER; RECOGNITION; TARGET; GENES;
D O I
10.2147/CMAR.S210305
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Purpose: ZMYND8 is closely correlated with cancerous proliferation and invasiveness. However, its prognostic value has not been estimated in a nasopharyngeal carcinoma (NPC). The purpose of this study was to elucidate the status of ZMYND8 expression and its prognostic significance in NPCs. Methods: The status of ZMYND8 expression was investigated by immunohistochemistry for NPC samples in the study. The cutoff value of ZMYND8 expression was confirmed in NPCs using ROC-curve analysis. Correlations between ZMYND8 expression and clinicopathological variables and patient prognosis were analyzed by various statistical methods. Results: Our study showed that low expression of ZMYND8 strongly correlated with late T stage in NPCs (P<0.05). Kaplan-Meier survival analysis revealed a significant association between low ZMYND8 expression and worse overall survival (P<0.05). Most importantly, Cox regression analysis confirmed ZMYND8 expression in NPC could be an independent prognostic factor. Conclusion: Low expression of ZMYND8 could be of importance, due to its displaying more aggressive behavior in NPC. Therefore, ZMYND8 expression might serve as an independent prediction factor in patients with NPCs.
引用
收藏
页码:7835 / 7843
页数:9
相关论文
共 25 条
  • [1] Selective Recognition of H3.1K36 Dimethylation/H4K16 Acetylation Facilitates the Regulation of All-trans-retinoic Acid (ATRA)-responsive Genes by Putative Chromatin Reader ZMYND8
    Adhikary, Santanu
    Sanyal, Sulagna
    Basu, Moitri
    Sengupta, Isha
    Sen, Sabyasachi
    Srivastava, Dushyant Kumar
    Roy, Siddhartha
    Das, Chandrima
    [J]. JOURNAL OF BIOLOGICAL CHEMISTRY, 2016, 291 (06) : 2664 - 2681
  • [2] Chemoradiotherapy versus radiotherapy in patients with advanced nasopharyngeal cancer: Phase III randomized intergroup study 0099
    Al-Sarraf, M
    LeBlanc, M
    Giri, PGS
    Fu, KK
    Cooper, J
    Vuong, T
    Forastiere, AA
    Adams, G
    Sakr, WA
    Schuller, DE
    Ensley, JF
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 1998, 16 (04) : 1310 - 1317
  • [3] Al-Sarraf Muhyi, 2002, Curr Treat Options Oncol, V3, P21
  • [4] BS69 and RACK7, a potential novel class of tumor suppressor genes
    Ansieau, S
    Sergeant, A
    [J]. PATHOLOGIE BIOLOGIE, 2003, 51 (07): : 397 - 399
  • [5] Cancer-Associated Protein Kinase C Mutations Reveal Kinase's Role as Tumor Suppressor
    Antal, Corina E.
    Hudson, Andrew M.
    Kang, Emily
    Zanca, Ciro
    Wirth, Christopher
    Stephenson, Natalie L.
    Trotter, Eleanor W.
    Gallegos, Lisa L.
    Miller, Crispin J.
    Fumari, Frank B.
    Hunter, Tony
    Brognard, John
    Newton, Alexandra C.
    [J]. CELL, 2015, 160 (03) : 489 - 502
  • [6] Chromatin reader ZMYND8 is a key target of all trans retinoic acid-mediated inhibition of cancer cell proliferation
    Basu, Moitri
    Khan, Md Wasim
    Chakrabarti, Partha
    Das, Chandrima
    [J]. BIOCHIMICA ET BIOPHYSICA ACTA-GENE REGULATORY MECHANISMS, 2017, 1860 (04): : 450 - 459
  • [7] Integrated genomic analyses of ovarian carcinoma
    Bell, D.
    Berchuck, A.
    Birrer, M.
    Chien, J.
    Cramer, D. W.
    Dao, F.
    Dhir, R.
    DiSaia, P.
    Gabra, H.
    Glenn, P.
    Godwin, A. K.
    Gross, J.
    Hartmann, L.
    Huang, M.
    Huntsman, D. G.
    Iacocca, M.
    Imielinski, M.
    Kalloger, S.
    Karlan, B. Y.
    Levine, D. A.
    Mills, G. B.
    Morrison, C.
    Mutch, D.
    Olvera, N.
    Orsulic, S.
    Park, K.
    Petrelli, N.
    Rabeno, B.
    Rader, J. S.
    Sikic, B. I.
    Smith-McCune, K.
    Sood, A. K.
    Bowtell, D.
    Penny, R.
    Testa, J. R.
    Chang, K.
    Dinh, H. H.
    Drummond, J. A.
    Fowler, G.
    Gunaratne, P.
    Hawes, A. C.
    Kovar, C. L.
    Lewis, L. R.
    Morgan, M. B.
    Newsham, I. F.
    Santibanez, J.
    Reid, J. G.
    Trevino, L. R.
    Wu, Y. -Q.
    Wang, M.
    [J]. NATURE, 2011, 474 (7353) : 609 - 615
  • [8] Decreased expression of PinX1 protein is correlated with tumor development and is a new independent poor prognostic factor in ovarian carcinoma
    Cai, Mu-Yan
    Zhang, Bin
    He, Wei-Peng
    Yang, Guo-Fen
    Rao, Hui-Lan
    Rao, Zhi-Yue
    Wu, Qiu-Liang
    Guan, Xin-Yuan
    Kung, Hsiang-Fu
    Zeng, Yi-Xin
    Xie, Dan
    [J]. CANCER SCIENCE, 2010, 101 (06) : 1543 - 1549
  • [9] ZMYND8 is a primary HIF coactivator that mediates breast cancer progression
    Chen, Yan
    Wang, Yingfei
    Luo, Weibo
    [J]. MOLECULAR & CELLULAR ONCOLOGY, 2018, 5 (04):
  • [10] The Chromatin Reader ZMYND8 Regulates Igh Enhancers to Promote Immunoglobulin Class Switch Recombination
    Delgado-Benito, Veronica
    Rosen, Daniel B.
    Wang, Qiao
    Gazumyan, Anna
    Pai, Joy A.
    Oliveira, Thiago Y.
    Sundaravinayagam, Devakumar
    Zhang, Wenzhu
    Andreani, Matteo
    Keller, Lisa
    Kieffer-Kwon, Kyong-Rim
    Pekowska, Aleksandra
    Jung, Seolkyoung
    Driesner, Madlen
    Subbotin, Roman, I
    Casellas, Rafael
    Chait, Brian T.
    Nussenzweig, Michel C.
    Di Virgilio, Michela
    [J]. MOLECULAR CELL, 2018, 72 (04) : 636 - +